CN Patent

CN118948773A — 1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物

Assigned to Deciphera Pharmaceuticals LLC · Expires 2024-11-15 · 2y expired

What this patent protects

本文提供的是包含由式(I)表示的化合物的低杂质组合物：其用于治疗与c‑KIT及PDGFRα激酶活性以及其致癌形式相关的病症。

USPTO Abstract

本文提供的是包含由式(I)表示的化合物的低杂质组合物：其用于治疗与c‑KIT及PDGFRα激酶活性以及其致癌形式相关的病症。

Drugs covered by this patent

Patent Metadata

Patent number: CN118948773A
Jurisdiction: CN
Classification: —
Expires: 2024-11-15
Drug substance claim: No
Drug product claim: No
Assignee: Deciphera Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.